NanoString Technologies Downgraded to Equal Weight at Morgan Stanley (NSTG)
NanoString Technologies (NASDAQ:NSTG) was downgraded by investment analysts at Morgan Stanley from an “overweight” rating to an “equal weight” rating in a note issued to investors on Monday, ARN reports. They currently have a $14.00 price objective on the stock. Morgan Stanley’s price target suggests a potential downside of 18.03% from the company’s current price.
Separately, analysts at Robert W. Baird upgraded shares of NanoString Technologies from a “neutral” rating to an “outperform” rating in a research note to investors on Wednesday, December 11th. They now have a $18.00 price target on the stock, up previously from $12.00.
Shares of NanoString Technologies (NASDAQ:NSTG) traded down 1.93% on Monday, hitting $16.75. The stock had a trading volume of 11,542 shares. NanoString Technologies has a 52-week low of $7.01 and a 52-week high of $18.09. The stock has a 50-day moving average of $14.21 and a 200-day moving average of $10.74. The company’s market cap is $244.8 million.
NanoString Technologies, Inc develops, manufactures and sells products, which unlock clinically actionable genomic information from minute amounts of tissue.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.